Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 7 | 2024 | 442 | 0.950 |
Why?
|
| Quality of Life | 3 | 2024 | 464 | 0.740 |
Why?
|
| Writing | 2 | 2012 | 14 | 0.640 |
Why?
|
| Neoplasms | 2 | 2016 | 755 | 0.530 |
Why?
|
| Mass Screening | 1 | 2014 | 141 | 0.420 |
Why?
|
| Survivors | 1 | 2012 | 36 | 0.390 |
Why?
|
| Indians, North American | 1 | 2016 | 511 | 0.380 |
Why?
|
| Cancer Survivors | 2 | 2024 | 39 | 0.360 |
Why?
|
| Cognitive Dysfunction | 3 | 2018 | 259 | 0.350 |
Why?
|
| Middle Aged | 9 | 2022 | 6817 | 0.260 |
Why?
|
| Thinking | 1 | 2005 | 11 | 0.240 |
Why?
|
| Education, Nursing | 1 | 2005 | 11 | 0.240 |
Why?
|
| Salicylates | 1 | 2024 | 3 | 0.230 |
Why?
|
| Ovarian Neoplasms | 2 | 2007 | 563 | 0.220 |
Why?
|
| Aged | 6 | 2018 | 5166 | 0.220 |
Why?
|
| Healthy Aging | 1 | 2022 | 5 | 0.200 |
Why?
|
| Memory, Episodic | 1 | 2022 | 18 | 0.200 |
Why?
|
| Humans | 14 | 2024 | 26826 | 0.190 |
Why?
|
| Female | 9 | 2024 | 14462 | 0.160 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 63 | 0.160 |
Why?
|
| Problem-Based Learning | 1 | 2019 | 60 | 0.160 |
Why?
|
| Education, Medical | 1 | 2019 | 61 | 0.160 |
Why?
|
| Cerebrum | 1 | 2018 | 14 | 0.160 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2018 | 31 | 0.160 |
Why?
|
| Muscarinic Agonists | 1 | 1998 | 9 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 1927 | 0.150 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 75 | 0.150 |
Why?
|
| Risk Assessment | 3 | 2014 | 587 | 0.150 |
Why?
|
| Adult | 6 | 2022 | 7382 | 0.150 |
Why?
|
| Hypoxia | 1 | 2018 | 85 | 0.150 |
Why?
|
| Terminal Care | 1 | 1998 | 43 | 0.150 |
Why?
|
| Students | 1 | 2019 | 188 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2016 | 51 | 0.130 |
Why?
|
| Cognition | 1 | 2018 | 294 | 0.130 |
Why?
|
| Social Support | 1 | 2016 | 123 | 0.120 |
Why?
|
| Qualitative Research | 1 | 2016 | 172 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2007 | 654 | 0.120 |
Why?
|
| Life Expectancy | 1 | 2014 | 20 | 0.120 |
Why?
|
| Aging | 2 | 2018 | 945 | 0.110 |
Why?
|
| Oklahoma | 1 | 2016 | 973 | 0.100 |
Why?
|
| Decision Making | 1 | 2014 | 169 | 0.100 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 117 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 388 | 0.090 |
Why?
|
| Emotions | 1 | 2012 | 131 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2004 | 537 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 802 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2012 | 209 | 0.090 |
Why?
|
| Prognosis | 1 | 2012 | 759 | 0.080 |
Why?
|
| Brain Mapping | 2 | 2022 | 199 | 0.080 |
Why?
|
| Ultrasonography, Mammary | 1 | 2007 | 3 | 0.070 |
Why?
|
| Ovariectomy | 1 | 2007 | 53 | 0.070 |
Why?
|
| Pedigree | 1 | 2007 | 153 | 0.070 |
Why?
|
| Mammography | 1 | 2007 | 77 | 0.070 |
Why?
|
| Brain | 2 | 2022 | 699 | 0.060 |
Why?
|
| Male | 2 | 2018 | 12869 | 0.060 |
Why?
|
| Genes, BRCA2 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Genes, BRCA1 | 1 | 2002 | 11 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2002 | 64 | 0.050 |
Why?
|
| Risk Factors | 1 | 2007 | 2010 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2022 | 118 | 0.050 |
Why?
|
| Nerve Net | 1 | 2022 | 105 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2001 | 114 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2019 | 58 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 74 | 0.040 |
Why?
|
| Perception | 1 | 2019 | 81 | 0.040 |
Why?
|
| Proteins | 1 | 2001 | 244 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 139 | 0.040 |
Why?
|
| Oxyhemoglobins | 1 | 2018 | 10 | 0.040 |
Why?
|
| Students, Medical | 1 | 2019 | 95 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 93 | 0.040 |
Why?
|
| Amnesia | 1 | 2017 | 9 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 173 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 243 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2018 | 189 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 390 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2017 | 127 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 290 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 918 | 0.030 |
Why?
|
| United States | 1 | 2019 | 2032 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2004 | 230 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2004 | 700 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2004 | 24 | 0.020 |
Why?
|
| Risk | 1 | 2004 | 133 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 182 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 75 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 198 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 262 | 0.010 |
Why?
|
| Alleles | 1 | 2001 | 345 | 0.010 |
Why?
|
| Base Sequence | 1 | 2001 | 573 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 508 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 1036 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 2957 | 0.010 |
Why?
|